| Literature DB >> 34517798 |
Li Liu1, Huiyun Wang2, Xiaoyun Chai3, Qingguo Meng1, Sheng Jiang4, Fenglan Zhao1.
Abstract
Ginsenoside Rh2 (3β-O-Glc-protopanaxadiol), a trace but characteristic pharmacological component of red ginseng, exhibited versatile pharmacological activities, such as antitumor effects, improved cardiac function and fibrosis, anti-inflammatory effects, antibiosis and excellent medicinal potential. In recent years, increased research has been performed on the biocatalytic synthesis of ginsenoside Rh2. In this paper, advances in the biocatalytic synthesis, pharmacological activities, pharmaceutical preparation and metabolism of ginsenoside Rh2 are reviewed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Ginsenoside Rh2; Panax notoginseng waste; biocatalytic synthesis; metabolism; pharmaceutical preparation; pharmacological activity
Mesh:
Substances:
Year: 2022 PMID: 34517798 DOI: 10.2174/1389557521666210913114631
Source DB: PubMed Journal: Mini Rev Med Chem ISSN: 1389-5575 Impact factor: 3.862